… Extracorporeal photopheresis (ECP) is an established treatment … This study's main objective
was to analyze the clinical … This multicenter observational retrospective study was conducted …

Background Extracorporeal photopheresis (ECP) is recommended as a second- or later-line
therapy for chronic GvHD (cGvHD). Benefits include reasonable response with avoidance …

… Extracorporeal photopheresis (ECP) is a recommended second or later line of therapy for …
In this single centre study, we attempted to evaluate not only therapeutic efficacy of ECP, but …

… observational retrospective study with the participation of four Turkish transplant centers,
100 patients with the diagnosis of steroid-refractory cGvHD who underwent ECP were analyzed…

… However, no study has evaluated infectious data and the risk factors for infection in patients
with GvHD treated by ECP. Thus, the objective of our retrospective study was to evaluate the …

Extracorporeal photopheresis (ECP) is a therapy that combines the collection of mononuclear
cells by apheresis, the addition of a photosensitizer (8-methoxisoralen), the illumination of …

… Extracorporeal photopheresis has also been used in combination with total skin electron
beam (TSEB) therapy. A retrospective study of 44 patients with erythrodermic MF/SS treated …

Full article: Outcomes of extracorporeal photopheresis in a diverse cohort of patients with
cutaneous T-cell lymphoma: a retrospective study at a tertiary care hospital Skip to Main …

… Potential limitations of our retrospective study are that first, our cohort is heterogeneous
with regard to age, time from GVHD onset to initiation of ECP, and use of different …

… Seeking to understand the efficacy of ECP in current practice, we conducted a retrospective
study including CTCL pts treated with ECP at Moffitt Cancer Center (MCC), FL, USA in the …